Clinical outcome and prognostic factors for Asian patients treated in a phase I study at the National University Cancer Institute, Singapore (NCIS).

Vaishnavi Muthu,Ross A. Soo,Wei Peng Yong,Soo-Chin Lee,Andrea Li Ann Wong,Wee Joo Chng,David Sp Tan,Valerie Heong,Boon-Cher Goh,Bee Choo Tai,Cheng Ean Chee

Clinical outcome and prognostic factors for Asian patients treated in a phase I study at the National University Cancer Institute, Singapore (NCIS).

2018

Vaishnavi Muthu
Ross A. Soo
Wei Peng Yong
Soo-Chin Lee
Andrea Li Ann Wong
Wee Joo Chng
David Sp Tan
Valerie Heong
Boon-Cher Goh
Bee Choo Tai
Cheng Ean Chee

e18748Background: Patient selection for phase I (P1) trials in oncology is challenging. A typical inclusion criterion for P1 studies is 'life expectancy > 3 months', however overall survival (OS) o...

Keywords:

Cancer
Pathology
Physical therapy
Medicine
Oncology
overall survival
Internal medicine
phase i study
Life expectancy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations